In January 2011, the FDA further announced it was asking manufacturers of prescription acetaminophen (APAP) combination products to limit the maximum amount of the drug in these products to 325 mg per tablet, capsule, or other dosage unit.
The FDA believes such a limitation will reduce the risk of hepatoxicity from acetaminophen (APAP) overdosing, a condition that could lead to liver failure, liver transplantation, and death.
Friday, December 9th
Saturday, December 10th
New Studio location: City Center Square